H2020
PARADIGM
Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes.
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 33 months
- Total cost
- EUR 9,127,316
- EU contribution
- EUR 4,498,931
- Participants
- 33 from 12 countries
- Topic
- H2020_IMI2-2016-10-07
- Grant agreement
- 777450
Coordinated by Forum des Patients Europeens (BEBelgium).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Forum des Patients Europeens | BEBelgium | Coordinator | EUR 702,516 | PIC (1.00) |
| Alexion Services Europe Sprl | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| European Forum for Good Clinical Practice | BEBelgium | Participant | EUR 198,000 | PIC (1.00) |
| Federation Europeenne D'Associations et D'Industries Pharmaceutiques | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Synergist Services | BEBelgium | Third party | Not stated | PIC (1.00) |
| The Synergist | BEBelgium | Participant | EUR 543,829 | PIC (1.00) |
| Ucb Biopharma | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Health Technology Assessment International Society | CACanada | Participant | EUR 0 | PIC (1.00) |
| Novartis Pharma AG | CHSwitzerland | Participant | EUR 0 | PIC (1.00) |
| Bayer Aktiengesellschaft | DEGermany | Participant | EUR 0 | PIC (1.00) |
| European Aids Treatment Group Ev | DEGermany | Participant | EUR 381,750 | PIC (1.00) |
| Grunenthal GmbH | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Merck Kommanditgesellschaft Auf Aktien | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Verband Forschender Arzneimittelhersteller Ev | DEGermany | Participant | EUR 0 | PIC (1.00) |
| H. Lundbeck As | DKDenmark | Participant | EUR 0 | PIC (1.00) |
| Novo Nordisk A/S | DKDenmark | Participant | EUR 0 | PIC (1.00) |
| Fundacio Privada Per a la Recerca i la Docencia Sant Joan de Deu | ESSpain | Participant | EUR 176,125 | PIC (1.00) |
| Instituto Aragones de Ciencias de la Salud | ESSpain | Participant | EUR 181,086 | known name (0.97) |
| Synapse Research Management Partners SL | ESSpain | Participant | EUR 399,595 | PIC (1.00) |
| Teamit Research SL | ESSpain | Participant | EUR 73,903 | PIC (1.00) |
| Eurordis - Rare Diseases Europe | FRFrance | Participant | EUR 463,598 | PIC (1.00) |
| Institut de Recherches Internationales Servier | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Amgen Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Glaxosmithkline Research & Development Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Labcorp Early Development Laboratories Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 621,593 | PIC (1.00) |
| Agenzia Italiana del Farmaco | ITItaly | Participant | EUR 50,000 | known name (0.95) |
| Alzheimer Europe | LULuxembourg | Participant | EUR 248,500 | PIC (1.00) |
| Stichting Vu | NLNetherlands | Participant | EUR 458,438 | known name (0.95) |
| Merck Sharp & Dohme Corp | USUnited States | Participant | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 33 participants from 12 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.